Quindell Share News (QPP)

Lloyds Banking Group shares are a 'hold', said Questor in the Sunday Telegraph. The bank is certainly making progress: reporting rising profits, is close to returning to paying a dividends and small investors will soon able to take advantage of the accelerated sale of the government's shareholding. Lloyds should be applauded for the progress it has made but, with some city experts believe all the good news is already in the share price, Questor's view was that investors should take a longer-term view if they are going to take part in the retail offer and not expect quick gains similar to those seen at Royal Mail after its government sell off. "It would be prudent to consider a world where impairments are higher than the current lows and a housing market that is slightly weaker. And those investing for income should be prepared for longer wait."Shares in Quindell are a speculative 'buy' for the Sunday Times's Inside the City column. Yes, the company has been a "corporate basketcase", having lost 90% of its value after a short-selling attack that led to the departure of its entire executive team. But "it is all change these days" with a £600m-plus wodge of cash in the bank after selling its legal services unit, a new crop of directors including former Conservative party leader Lord Howard of Lympne, and the only remaining business its telematics arm. This division, which uses "black boxes" to monitor driver behaviour, has drawn the interest of tycoon Edi Truell, who has made a reported £60m offer. Quindell has said nothing about the bid and next month it is due to reveals annual accounts that reflect new management's more "conservative" accounting practices, which could look "very ugly". But this recommendation is about looming cash return of which, potentially, there's a lot to share around.Investors should 'buy' shares in Quantum Pharmaceutical for the long-term, said Midas in the Mail on Sunday. With the NHS under extremely pressure to save money, Quantum has developed a system that could cut costs by reducing wastage from older patients not taking their prescribed drugs. The company's main business is reformulating medicines for specific needs, known as 'special obtains', such as turning drugs that are normally administered as tablets into a liquid form for those having difficulty swallowing, creating treatments for allergy sufferers and taking alcohol out of medicine for children. It used to work exclusively with pharmacies, but has begun to supply hospitals with special drugs as well as intravenous medication. Moreover it has created what it says is the first ever medicine tray that can contain liquids and tablets and is piloting a system where the tray monitors if a patient has taken their medicine at the right time, reminding older patients to take their pills, or alerting a carer.Please note: Digital Look provides a round-up of news, tips and information that is impacting share prices and the market. Digital Look cannot take any responsibility for information provided by third parties. This is for your general information only and not intended to be relied upon by users in making an investment decision or any other decision. Please obtain a copy of the relevant publication and carry out your own research before considering acting on any of this information.